AAAAAA

   
Results: 1-25 | 26-50 | 51-74
Results: 1-25/74
MULTICYCLIC DOSE-INTENSIVE CHEMOTHERAPY WITH CIRCULATING PROGENITOR-CELL SUPPORT FOR HIGH-RISK PRIMARY BREAST-CANCER
Authors: DANOVA M PEROTTI C MORA O LUCOTTI C TORRETTA L COMOLLI G RICCARDI A SALVANESCHI L ASCARI E
Citation: M. Danova et al., MULTICYCLIC DOSE-INTENSIVE CHEMOTHERAPY WITH CIRCULATING PROGENITOR-CELL SUPPORT FOR HIGH-RISK PRIMARY BREAST-CANCER, Oncology Reports, 5(2), 1998, pp. 427-429
THE EFFECTIVENESS AND TOLERABILITY OF EPOETIN-ALPHA IN PATIENTS WITH MULTIPLE-MYELOMA REFRACTORY TO CHEMOTHERAPY
Authors: DAMMACCO F SILVESTRIS F CASTOLDI GL GRASSI B BERNASCONI C NADALI G PERONA G DELAURENZI A TORELLI U ASCARI E FERRINI PLR CALIGARISCAPPIO F PILERI A RESEGOTTI L
Citation: F. Dammacco et al., THE EFFECTIVENESS AND TOLERABILITY OF EPOETIN-ALPHA IN PATIENTS WITH MULTIPLE-MYELOMA REFRACTORY TO CHEMOTHERAPY, International journal of clinical & laboratory research, 28(2), 1998, pp. 127-134
RECENT ADVANCES IN MYELODYSPLASTIC SYNDROMES (MDS)
Authors: ASCARI E
Citation: E. Ascari, RECENT ADVANCES IN MYELODYSPLASTIC SYNDROMES (MDS), Haematologica, 83(3), 1998, pp. 287-288
DIAGNOSIS AND TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY-HYPERTENSION (CTPH) - THE PAVIA THROMBOENDARTERECTOMY PROGRAM
Authors: PIOVELLA F MINZIONI G EMMI V BARONE M SERAFINI S BELTRAMETTI C SIRAGUSA S DARMINI A BARZAGHI N PASSERA R TABORELLI P CERVERI I RECUSANI F DORE R VIGANO M BRASCHI A ASCARI E
Citation: F. Piovella et al., DIAGNOSIS AND TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY-HYPERTENSION (CTPH) - THE PAVIA THROMBOENDARTERECTOMY PROGRAM, Thrombosis research, 91(3), 1998, pp. 245-245
THE COMBINED USE OF ILOPROST AND DANAPAROID IN THE SURGICAL-MANAGEMENT OF A PATIENT WITH CHRONIC THROMBOEMBOLIC PULMONARY-HYPERTENSION AND HEPARIN-INDUCED THROMBOCYTOPENIA
Authors: SERAFINI S BARZAGHI N BARONE M BELTRAMETTI C SIRAGUSA S MINZIONI G EMMI V DARMINI A VIGANO M BRASCHI A ASCARI E PIOVELLA F
Citation: S. Serafini et al., THE COMBINED USE OF ILOPROST AND DANAPAROID IN THE SURGICAL-MANAGEMENT OF A PATIENT WITH CHRONIC THROMBOEMBOLIC PULMONARY-HYPERTENSION AND HEPARIN-INDUCED THROMBOCYTOPENIA, Thrombosis research, 91(3), 1998, pp. 250-250
EXPRESSION OF P53, BCL-2 AND RAS ONCOPROTEINS IN ACUTE LEUKEMIAS AND MYELODYSPLASTIC SYNDROMES
Authors: INVERNIZZI R PECCI A BELLOTTI L FORMISANO R ASCARI E
Citation: R. Invernizzi et al., EXPRESSION OF P53, BCL-2 AND RAS ONCOPROTEINS IN ACUTE LEUKEMIAS AND MYELODYSPLASTIC SYNDROMES, British Journal of Haematology, 102(1), 1998, pp. 166-166
GIANT-CELLS IN VIRUS-INDUCED HEMATOLOGICAL DISORDERS
Authors: MAZUR G SITAR G MANENTI L ASCARI E
Citation: G. Mazur et al., GIANT-CELLS IN VIRUS-INDUCED HEMATOLOGICAL DISORDERS, British Journal of Haematology, 102(1), 1998, pp. 169-169
RELEVANCE OF AGE ON SURVIVAL OF 341 PATIENTS WITH MULTIPLE-MYELOMA TREATED WITH CONVENTIONAL CHEMOTHERAPY - UPDATED RESULTS OF THE MM87 PROSPECTIVE RANDOMIZED PROTOCOL
Authors: RICCARDI A MORA O BRUGNATELLI S TINELLI C SPANEDDA R DEPAOLI A BARBARANO L DISTASI M BERGONZI C GIORDANO M DELFINI C NICOLETTI G RINALDI E PICCININI L VALENTINI D ASCARI E
Citation: A. Riccardi et al., RELEVANCE OF AGE ON SURVIVAL OF 341 PATIENTS WITH MULTIPLE-MYELOMA TREATED WITH CONVENTIONAL CHEMOTHERAPY - UPDATED RESULTS OF THE MM87 PROSPECTIVE RANDOMIZED PROTOCOL, British Journal of Cancer, 77(3), 1998, pp. 485-491
CONGENITAL ERYTHROPOIETIN-DEPENDENT ERYTHROCYTOSIS RESPONSIVE TO THEOPHYLLINE TREATMENT
Authors: CAZZOLA M GUARNONE R CERANI P ROVATI A ASCARI E
Citation: M. Cazzola et al., CONGENITAL ERYTHROPOIETIN-DEPENDENT ERYTHROCYTOSIS RESPONSIVE TO THEOPHYLLINE TREATMENT, Blood, 91(1), 1998, pp. 360-361
C-REACTIVE PROTEIN AND ALBUMIN IN PANCREATIC-CANCER
Authors: PUGLIESE P GIRINO M DEMEDICI A RICCARDI A ASCARI E
Citation: P. Pugliese et al., C-REACTIVE PROTEIN AND ALBUMIN IN PANCREATIC-CANCER, European journal of cancer, 33, 1997, pp. 1279-1279
IDARUBICIN AND CYTOSINE-ARABINOSIDE IN THE INDUCTION AND MAINTENANCE THERAPY OF HIGH-RISK MYELODYSPLASTIC SYNDROMES
Authors: INVERNIZZI R PECCI A ROSSI G PELIZZARI AM GIUSTO M TINELLI C ASCARI E
Citation: R. Invernizzi et al., IDARUBICIN AND CYTOSINE-ARABINOSIDE IN THE INDUCTION AND MAINTENANCE THERAPY OF HIGH-RISK MYELODYSPLASTIC SYNDROMES, Haematologica, 82(6), 1997, pp. 660-663
ANTIPLATELET AGENTS IN THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) - RESULTS OF A RANDOMIZED MULTICENTER TRIAL BY THE ITALIAN-COOPERATIVE-GROUP FOR TTP
Authors: BOBBIOPALLAVICINI E GUGLIOTTA L CENTURIONI R PORTA C VIANELLI N BILLIO A TACCONI F ASCARI E
Citation: E. Bobbiopallavicini et al., ANTIPLATELET AGENTS IN THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) - RESULTS OF A RANDOMIZED MULTICENTER TRIAL BY THE ITALIAN-COOPERATIVE-GROUP FOR TTP, Haematologica, 82(4), 1997, pp. 429-435
ANOTHER STEP FORWARD ALONG THE EUROPEAN WAY
Authors: ASCARI E CAZZOLA M
Citation: E. Ascari et M. Cazzola, ANOTHER STEP FORWARD ALONG THE EUROPEAN WAY, Haematologica, 82(1), 1997, pp. 1-1
CHARACTERIZATION OF THE BIOPHYSICAL PROPERTIES OF HUMAN ERYTHROBLASTSAS A PRELIMINARY STEP TO THE ISOLATION OF FETAL ERYTHROBLASTS FROM MATERNAL PERIPHERAL-BLOOD FOR NON INVASIVE PRENATAL GENETIC INVESTIGATION
Authors: SITAR G MANENTI L FARINA A LANATI V MASCHERETTI P FORABOSCO A MONTANARI L ASCARI E
Citation: G. Sitar et al., CHARACTERIZATION OF THE BIOPHYSICAL PROPERTIES OF HUMAN ERYTHROBLASTSAS A PRELIMINARY STEP TO THE ISOLATION OF FETAL ERYTHROBLASTS FROM MATERNAL PERIPHERAL-BLOOD FOR NON INVASIVE PRENATAL GENETIC INVESTIGATION, Haematologica, 82(1), 1997, pp. 5-10
POSTOPERATIVE MANAGEMENT OF CHRONIC MAJOR VESSEL THROMBOEMBOLIC PULMONARY-HYPERTENSION
Authors: EMMI V PIOVELLA F MINZIONI G SERAFINI S TOSI P BARONE M BELTRAMETTI C TABORELLI P CERVERI I RECUSANI F APRILE C BARZAGHI N VIGANO M BRASCHI A ASCARI E
Citation: V. Emmi et al., POSTOPERATIVE MANAGEMENT OF CHRONIC MAJOR VESSEL THROMBOEMBOLIC PULMONARY-HYPERTENSION, Thrombosis and haemostasis, 1997, pp. 1995-1995
A MULTIDISCIPLINARY APPROACH TO CHRONIC MAJOR VESSEL THROMBOEMBOLIC PULMONARY-HYPERTENSION - ANALYSIS OF INITIAL RESULTS
Authors: PIOVELLA F MINZIONI G EMMI V AUGER W BRISTER S SERAFINI S TOSI P DARMINI A BARONE M BELTRAMETTI C SIRAGUSA S FRACCHIA C VIGANO M BRASCHI A ASCARI E
Citation: F. Piovella et al., A MULTIDISCIPLINARY APPROACH TO CHRONIC MAJOR VESSEL THROMBOEMBOLIC PULMONARY-HYPERTENSION - ANALYSIS OF INITIAL RESULTS, Thrombosis and haemostasis, 1997, pp. 2913-2913
LOW-MOLECULAR-WEIGHT HEPARIN IN THE TREATMENT OF PATIENTS WITH VENOUSTHROMBOEMBOLISM
Authors: TENCATE JW BULLER HR GENT M HIRSH J PRINS MH BAILDON R LENSING AWA ANDERSON DR VANBEEK EJR FIESINGER JN TIJSSEN JGP VANBARNEVELD A EIMERS LT GRAAFSMA YP HETTIARACHCHI R HUTTEN B REDEKOP K HALEY S LIBERALE L FINCH T WHITTAKER S WILKINSON L PRANDONI P VILLALTA S GIROLAMI B BAGATELLA P ROSSI L GIROLAMI A PIOVELLA F BARONE M BELTRAMETTI C SERAFINI S SIRAGUSA S ASCARI E KOVACS MJ MORROW B KOVACS J KUIJER PMM KOOPMAN MMW JAGT H WEITZ J KEARON C BIAGIONI L HAAS S LOSSNER F SPENGEL FA BERGER M DEMERS C POULIN J VANDERMEER J QUE GTH SMID WM ROBINSON KS BOYLE E LECLERC JR STJACQUES B FINKENBINE S GALLUS AS COHLAN D RICH C BRANDJES DPM HOEFNAGEL CA DERIJK M TURKSTRA F DESJARDINS L COTEDESJARDINS J COUTURE L RUEL M VILLENUEVE J GEERTS WH JAY RM CODE EKI TURPIE AGG JOHNSON J NGUYEN P CUSSON JR ROY S WELLS PS BORMANIS J GOUDIE D CRUICKSHANK M VONLEWINSKI M MONREAL M SAHUQUILLO JC LAFOZ E SIMONNEAU G PARENT F JAGOT J DOUKETIS JD KINNON K GINSBERG JS BRILLEDWARDS P DONOVAN D OCKELFORD PA KASSIS J BORNAIS S PLANCHON B ELKOURI D PISTORIUS MA ESCRIBANO M GARRIDO G CHESTERMAN CN CHONG BH PRITCHARD S CADE JF BYNON T STANFORD J BRIEN WM PALMER B FAIVRE R PETITEAU B MANUCCI PM MOIA M BUCCIARELLI P
Citation: Jw. Tencate et al., LOW-MOLECULAR-WEIGHT HEPARIN IN THE TREATMENT OF PATIENTS WITH VENOUSTHROMBOEMBOLISM, The New England journal of medicine, 337(10), 1997, pp. 657-662
MEMBRANE CD22 DEFINES CIRCULATING MYELOMA-RELATED CELLS AS MATURE OR LATER B-CELLS
Authors: PERFETTI V VIGNARELLI MC BELLOTTI V GLENNIE MJ ZORZOLI I UBBIALI P OBICI L MASSA M IPPOLITI G ASCARI E MERLINI G
Citation: V. Perfetti et al., MEMBRANE CD22 DEFINES CIRCULATING MYELOMA-RELATED CELLS AS MATURE OR LATER B-CELLS, Laboratory investigation, 77(4), 1997, pp. 333-344
BOTH CYCLING AND NONCYCLING PRIMITIVE PROGENITORS CONTINUE TO BE MOBILIZED INTO THE CIRCULATION DURING THE LEUKAPHERESIS OF PATIENTS PRETREATED WITH CHEMOTHERAPY AND G-CSF
Authors: PONCHIO L EAVES C HOGGE D PEROTTI C TORRETTA L CERANI P SALVANESCHI L ASCARI E CAZZOLA M
Citation: L. Ponchio et al., BOTH CYCLING AND NONCYCLING PRIMITIVE PROGENITORS CONTINUE TO BE MOBILIZED INTO THE CIRCULATION DURING THE LEUKAPHERESIS OF PATIENTS PRETREATED WITH CHEMOTHERAPY AND G-CSF, British Journal of Haematology, 99(2), 1997, pp. 394-402
THE PREVALENCE OF HYPERCOAGULABLE STATE AMONG PATIENTS WITH CHRONIC MAJOR VESSEL THROMBOEMBOLIC PULMONARY-HYPERTENSION
Authors: PIOVELLA F MINZIONI G EMMI V SERAFINI S BARONE M BELTRAMETTI C TOSI P DARMINI A BARZAGHI N SIRAGUSA S VIGANO M BRASCHI A ASCARI E
Citation: F. Piovella et al., THE PREVALENCE OF HYPERCOAGULABLE STATE AMONG PATIENTS WITH CHRONIC MAJOR VESSEL THROMBOEMBOLIC PULMONARY-HYPERTENSION, Blood, 90(10), 1997, pp. 3253-3253
COMPARISON OF IDARUBICIN VS EPIDOXORUBICIN-CONTAINING PROMACE-CYTABOMREGIMENS IN UNTREATED AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL) - FINAL RESULTS OF A MULTICENTER RANDOMIZED TRIAL OF THE ITALIAN LYMPHOMA STUDY-GROUP (GISL)
Authors: BRUGIATELLI M FEDERICO M GOBBI P DIRENZO N VALLISA D ANGRILLI F COLOMBI M ASCARI E SILINGARDI V AMADORI S
Citation: M. Brugiatelli et al., COMPARISON OF IDARUBICIN VS EPIDOXORUBICIN-CONTAINING PROMACE-CYTABOMREGIMENS IN UNTREATED AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL) - FINAL RESULTS OF A MULTICENTER RANDOMIZED TRIAL OF THE ITALIAN LYMPHOMA STUDY-GROUP (GISL), Blood, 90(10), 1997, pp. 840-840
INTERNATIONAL PROGNOSTIC SCORING SYSTEM AND OTHER PROGNOSTIC SYSTEMS FOR MYELODYSPLASTIC SYNDROMES
Authors: BALDUINI CL GUARNONE R PECCI A CENTENARA E ASCARI E
Citation: Cl. Balduini et al., INTERNATIONAL PROGNOSTIC SCORING SYSTEM AND OTHER PROGNOSTIC SYSTEMS FOR MYELODYSPLASTIC SYNDROMES, Blood, 90(10), 1997, pp. 4232-4233
SEQUENTIAL ADMINISTRATION OF INTERLEUKIN-3 AND GRANULOCYTE-MACROPHAGECOLONY-STIMULATING FACTOR FOLLOWING INTENSIFIED, ACCELERATED CEE (CYCLOPHOSPHAMIDE, EPIRUBICIN, ETOPOSIDE) CHEMOTHERAPY IN PATIENTS WITH SOLID TUMORS - CYTOKINETIC EFFECTS ON BONE-MARROW HEMATOPOIETIC PROGENITORS
Authors: DANOVA M MAZZINI G ALBERICI R LUCOTTI C PALMERI S FINCATO G CAZZOLA M RICCARDI A ASCARI E
Citation: M. Danova et al., SEQUENTIAL ADMINISTRATION OF INTERLEUKIN-3 AND GRANULOCYTE-MACROPHAGECOLONY-STIMULATING FACTOR FOLLOWING INTENSIFIED, ACCELERATED CEE (CYCLOPHOSPHAMIDE, EPIRUBICIN, ETOPOSIDE) CHEMOTHERAPY IN PATIENTS WITH SOLID TUMORS - CYTOKINETIC EFFECTS ON BONE-MARROW HEMATOPOIETIC PROGENITORS, International journal of oncology, 9(5), 1996, pp. 971-976
ORAL IDARUBICIN AND PREDNISONE FOR ADVANCED, PREVIOUSLY UNTREATED, MULTIPLE-MYELOMA - A PILOT-STUDY
Authors: BRUGNATELLI S RICCARDI A UCCI G PETRINI M GIORDANO M BARBARANO L BERGONZI C DEPAOLI A CAVANNA L ASCARI E
Citation: S. Brugnatelli et al., ORAL IDARUBICIN AND PREDNISONE FOR ADVANCED, PREVIOUSLY UNTREATED, MULTIPLE-MYELOMA - A PILOT-STUDY, Annals of oncology, 7(5), 1996, pp. 537-538
VINBLASTINE, BLEOMYCIN, AND METHOTREXATE CHEMOTHERAPY PLUS EXTENDED-FIELD RADIOTHERAPY IN EARLY, FAVORABLY PRESENTING, CLINICALLY STAGED HODGKINS PATIENTS - THE GRUPPO-ITALIANO-PER-LO-STUDIO-DEI-LINFOMI EXPERIENCE
Authors: GOBBI PG PIERESCA C FRASSOLDATI A CAROTENUTO M DIRENZO N LASALA A BERTE R AVANZINI P FEDERICO M SILINGARDI V ASCARI E
Citation: Pg. Gobbi et al., VINBLASTINE, BLEOMYCIN, AND METHOTREXATE CHEMOTHERAPY PLUS EXTENDED-FIELD RADIOTHERAPY IN EARLY, FAVORABLY PRESENTING, CLINICALLY STAGED HODGKINS PATIENTS - THE GRUPPO-ITALIANO-PER-LO-STUDIO-DEI-LINFOMI EXPERIENCE, Journal of clinical oncology, 14(2), 1996, pp. 527-533
Risultati: 1-25 | 26-50 | 51-74